SUMO2 and ALAS1

  • Number of citations of the paper that reports this interaction (PMID 21900206)
  • 27
  • Data Source:
  • BioGRID (two hybrid)

SUMO2

ALAS1

Gene Name small ubiquitin-like modifier 2 5-aminolevulinate synthase 1
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 91 interactors: ALAS1 ARL13A ARNTL ATXN1 ATXN7 AURKB BAD BCL11A BLM BRCC3 BRE C18orf25 CCNE2 CDCA8 CENPC CHAF1A CHD3 CMTM6 CORO2A CSNK2B CUL3 FAM175A FOS HDAC4 HDAC9 HIF1A HIPK2 HNF4A HOMEZ HSF2 JUN KALRN KDM1A KRT14 KRT5 KRT8 LEF1 MAF1 MAST2 MDC1 MSX1 MYB NFKBIA PARP1 PIAS1 PIAS2 PIAS3 PIAS4 PML RAC1 RANGAP1 RB1 RNF111 RNF4 SAE1 SENP1 SENP2 SENP3 SENP5 SENP6 SENP7 SETDB1 SETX SH3KBP1 SLC22A2 SNCA SOX10 SOX6 SP100 STK24 SUMO1 TDG TDP2 TEAD3 TNIP1 TOPORS TP53BP2 TRIM63 UBA2 UBE2I USP25 USPL1 VIM WRN XPC ZBTB1 ZCCHC12 ZCCHC7 ZHX1 ZMYM2 ZMYM5 40 interactors: BCL7A C2orf42 C8orf33 CCHCR1 CDC73 CDK5 CDKN1A CERK DUSP19 EP400 FAM127C GNL3L KLHL35 LONRF1 MTFR2 NUDT3 PIK3CB PLAU POLDIP2 PPL RAP1B SH2D4A SNX20 STAMBP SUMO2 TCEA2 TEKT4 TK1 TMSB10 TMSB4X TMSB4XP1 TMSB4XP2 TMSB4XP6 TTC23 USP20 WIPF1 ZFYVE26 ZMAT1 ZNF175 ZNF564
Entrez ID 6613 211
HPRD ID 04332 00505
Ensembl ID ENSG00000188612 ENSG00000023330
Uniprot IDs P61956 P13196 Q5JAM2
PDB IDs 1WM2 1WM3 1WZ0 1Z5Q 2AWT 2CKH 2D07 2IO0 2IO3 2IYD 2RPQ 3UIN 3UIO
Enriched GO Terms of Interacting Partners?
Tagcloud ?
augment  consequent  delaying  elusive  emerged  enhance  enhancing  facilitates  fasting  fate  linking  maintenance  melanoma  modifications  modified  node  nutrient  partner  promising  relief  rev1  sensing  short  specialized  starvation  suppressor  therapies  toxic  turn 
adequate  arf1  candidate  eif2b1  fbxw2  genorm  gusb  housekeeping  hprt1  hysterectomy  ideal  leiomyoma  menopausal  menstrual  mrpl19  myometrial  myometrium  normalization  normfinder  phases  proliferative  pum1  regardless  secretory  softwares  standards  taqman  trim27  ube2d2 
Tagcloud (Difference) ?
augment  consequent  delaying  elusive  emerged  enhance  enhancing  facilitates  fasting  fate  linking  maintenance  melanoma  modifications  modified  node  nutrient  partner  promising  relief  rev1  sensing  short  specialized  starvation  suppressor  therapies  toxic  turn 
adequate  arf1  candidate  eif2b1  fbxw2  genorm  gusb  housekeeping  hprt1  hysterectomy  ideal  leiomyoma  menopausal  menstrual  mrpl19  myometrial  myometrium  normalization  normfinder  phases  proliferative  pum1  regardless  secretory  softwares  standards  taqman  trim27  ube2d2 
Tagcloud (Intersection) ?